Advertisement
ADVANCED SEARCH

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Milionis, H. J. Articles by Elisaf, M. S. Search for Related Content PubMed PubMed Citation Articles by Milionis, H. J. Articles by Elisaf, M. S.

The hyponatremic patient: a systematic approach to laboratory diagnosis

From the Department of Internal Medicine, University of Ioannina Medical School, Ioannina, Greece

Correspondence to: Dr. Moses S. Elisaf, Department of Internal Medicine, University of Ioannina Medical School, GR 451 10 Ioannina, Greece; fax +30 651 097016

Abstract

HYPONATREMIA (SERUM SODIUM LEVEL LESS THAN 134 MMOL/L) is a common electrolyte disturbance. Its high prevalence and potential neurologic sequelae make a logical and rigorous differential diagnosis mandatory before any therapeutic intervention. A history of concurrent illness and medication use as well as the assessment of extracellular volume status on physical examination may provide useful clues as to the pathogenesis of hyponatremia. Measurement of the effective serum tonicity (serum osmolality less serum urea level) is the first step in the laboratory evaluation. In patients with normal or elevated effective serum osmolality (280 mOsm/kg or greater), pseudohyponatremia should be excluded. In the hypo-osmolar state (serum osmolality less than 280 mOsm/kg), urine osmolality is used to determine whether water excretion is normal or impaired. A urine osmolality value of less than 100 mOsm/kg indicates complete and appropriate suppression of antidiuretic hormone secretion. A urine sodium level less than 20 mmol/L is indicative of hypovolemia, whereas a level greater than 40 mmol/L is suggestive of the syndrome of inappropriate antidiuretic hormone secretion. Levels of hormones (thyroid-stimulating hormone and cortisol) and arterial blood gases should be determined in difficult cases of hyponatremia.

This article has been cited by other articles:

				K. Liapis, J. Apostolidis, E. Charitaki, F. Panitsas, N. Harhalakis, and E. Nikiforakis Syndrome of Inappropriate Secretion of Antidiuretic Hormone Associated with Imatinib Ann. Pharmacother., December 1, 2008; 42(12): 1882 - 1886. [Abstract] [Full Text] [PDF]

				W S A Smellie, K K Hampton, R Bowlees, S C Martin, N Shaw, J Hoffman, J P Ng, S M Mackenzie, and C van Heyningen Best practice in primary care pathology: review 8 J. Clin. Pathol., July 1, 2007; 60(7): 740 - 748. [Abstract] [Full Text] [PDF]

				D. H. Ellison and T. Berl The Syndrome of Inappropriate Antidiuresis N. Engl. J. Med., May 17, 2007; 356(20): 2064 - 2072. [Full Text] [PDF]

				W S. A Smellie and A Heald Hyponatraemia and hypernatraemia: pitfalls in testing BMJ, March 3, 2007; 334(7591): 473 - 476. [Full Text] [PDF]

				J. K. Ghali, M. J. Koren, J. R. Taylor, E. Brooks-Asplund, K. Fan, W. A. Long, N. Smith, and for the Conivaptan Study Group Efficacy and Safety of Oral Conivaptan: A V1A/V2 Vasopressin Receptor Antagonist, Assessed in a Randomized, Placebo-Controlled Trial in Patients with Euvolemic or Hypervolemic Hyponatremia J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2145 - 2152. [Abstract] [Full Text] [PDF]

				E.J. Hoorn, M.L. Halperin, and R. Zietse Diagnostic approach to a patient with hyponatraemia: traditional versus physiology-based options QJM, July 1, 2005; 98(7): 529 - 540. [Abstract] [Full Text] [PDF]

				C. P. Thomas, R. W. Loftus, and K. Z. Liu AVP-induced VIT32 gene expression in collecting duct cells occurs via trans-activation of a CRE in the 5'-flanking region of the VIT32 gene Am J Physiol Renal Physiol, September 1, 2004; 287(3): F460 - F468. [Abstract] [Full Text] [PDF]

				H. J. Milionis and M. S. Elisaf Metabolic alkalosis in patients with renal failure Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1932 - 1932. [Full Text] [PDF]

				K. E. Yeates, M. Singer, and A. R. Morton Salt and water: a simple approach to hyponatremia Can. Med. Assoc. J., February 3, 2004; 170(3): 365 - 369. [Abstract] [Full Text] [PDF]

				G. Miltiadous, D. P. Mikhailidis, and M. Elisaf Acid-Base and Electrolyte Abnormalities Observed in Patients Receiving Cardiovascular Drugs Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2003; 8(4): 267 - 276. [Abstract] [PDF]

				S. Smitz Hyponatremia and SIADH Can. Med. Assoc. J., September 1, 2002; 167(5): 449 - 450. [Full Text]

HOME	CURRENT ISSUE	PAST ISSUES	COLLECTIONS	HELP	SEARCH
Copyright 1995-2002, Canadian Medical Association. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p) All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.